We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Toxic Oil Syndrome

Francisco Díaz de Rojas, MD; Ignacio Abaitua Borda, MD; Manuel Posada de la Paz, MD; Mercedes Castro García, MD; José Maria Alonso Gordo, MD; Juan Manuel Tabuenca Oliver, MD
Arch Intern Med. 1985;145(3):578. doi:10.1001/archinte.1985.00360030230057.
Text Size: A A A
Published online


To the Editor.  —The study by Gilsanz et al1 on the evolution of 317 patients suffering from toxic oil syndrome (TOS) includes a number of data on which we would like to comment.First, we are surprised by the low incidence of eosinophilia (40%) in relation to other series,2 which even reached 98%. In 1,500 patients followed up by us, eosinophilia appeared in 86.4% of the patients. Similarly, we noticed the lack of data on hepatopathy. In our series, during the first six months, 20.1% of the patients had hepatopathy, after one year 21.5%, and after two years 19%. The clinical data demonstrate cytolytic, cholestatic, and mixed patterns. This affection corresponds to histologic alterations,3 with inflammatory, degenerative, and microscopic cholestatic changes.The incidence of mitral prolapse in the series referred to by Gilsanz et al was 21% (4/19) and not 31% which, because of the small number


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.